APAC Michael Page
Exxon Mobil
NTT DATA North America
Mission Consultancy Services
KPMG in Malaysia
Connect with headhunters to apply for similar jobsY.H. Engineering Consultant
Deloitte PLT
WINE ADORE
A leading healthcare recruitment agency in Malaysia seeks a Clinical Trial Payment & P2P Analyst (Korean Speaker) to manage P2P processes and support clinical trial payments. The ideal candidate has a Bachelor's degree in Finance or Accounting and is fluent in both Korean and English. This role offers a competitive salary and opportunities for growth in the Life Science industry.
As a Clinical Trial Payment & P2P Analyst (Korean Speaker) in the Life Science industry, you will manage procurement-to-pay processes while utilizing your Korean language skills. This role requires attention to detail and the ability to communicate effectively in a multicultural environment.
We are partnering with a global leader in healthcare and life sciences, recognised for its commitment to improving lives through innovative medicines and advanced clinical research. This organisation offers a dynamic and collaborative environment where your work directly contributes to global health initiatives. If you are looking for a role that combines purpose, professional growth, and impact, this is an excellent opportunity to join a team that values excellence and continuous learning.
A successful Clinical Trial Payment & P2P Analyst (Korean Speaker) should:
If you are fluent in Korean and passionate about Accounting & Finance, apply now to join a leading organization in the Life Science industry!
To apply online please click the 'Apply' button below. For a confidential discussion about this role please contact Yin Ern Ngo +60323024029.
Agensi Pekerjaan Michael Page International () Sdn Bhd | Registration No.914741-W.
* The salary benchmark is based on the target salaries of market leaders in their relevant sectors. It is intended to serve as a guide to help Premium Members assess open positions and to help in salary negotiations. The salary benchmark is not provided directly by the company, which could be significantly higher or lower.